Facts and figures

Virtually everything you need to know about us, from our R&D and products to our management team and history.

Company Operations in more than 40 countries worldwide….
Key strengths A leader in allergy and epilepsy, as well as antibody research…
Financials Revenue of €3.6 billion in 2007.…
Sales With net sale of more than €32 billion in 84 countries….
Products From Keppra® and Xyzal® to Neupro®, products for specialists and primary care…
Pipeline 12 molecules in development, including five large molecules and seven small molecules…..
A global R&D, marketing and sales platform Operations in more than 40 countries worldwide. Ten R&D sites across Europe, Japan and the United State.
Partners Over 30 R&D and commercial partners, from Amgen to Pfizer…
Management and staff An experienced, multinational management team and staff…
History Established in 1928, transformed into a pure biopharma in 2004…